NICE LTD. (NICE) Spending and interest coverage
- R&D / revenue · 12 months: Value 12.24%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value 4.96%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 12.24% | Research and development expense / revenue. Period ending 2025-12-31. $360.45M ÷ $2.95B × 100 ≈ 12.24% |
| Stock-based compensation / revenue · 12 months | 4.96% | Share-based compensation / revenue. Period ending 2025-12-31. $146.05M ÷ $2.95B × 100 ≈ 4.96% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 360.45M USD | Research and Development Expense |
| Revenue | 2.95B USD | |
| Stock-based compensation | 146.05M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 645.76M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $360.45M | $2.95B | $146.05M | $645.76M | (m) | 12.24% | 4.96% | (m) | (m) |
| 2024-12-31 | $360.61M | $2.74B | $182.07M | $545.95M | (m) | 13.18% | 6.66% | (m) | (m) |
| 2023-12-31 | $322.71M | $2.38B | $176.66M | $435.23M | $1.10M | 13.57% | 7.43% | 395.30× | Reported |
| 2022-12-31 | $306.07M | $2.18B | $182.70M | $335.17M | $1.13M | 14.03% | 8.38% | 297.40× | Reported |
| 2021-12-31 | $271.19M | $1.92B | $153.03M | $263.91M | $10.06M | 14.12% | 7.97% | 26.23× | Reported |
| 2020-12-31 | $218.18M | $1.65B | $101.67M | $242.05M | $7.77M | 13.24% | 6.17% | 31.15× | Reported |
| 2019-12-31 | $193.72M | $1.57B | $80.86M | $238.72M | $11.68M | 12.31% | 5.14% | 20.43× | Reported |
| 2018-12-31 | $183.83M | $1.44B | $67.22M | $197.62M | $11.20M | 12.73% | 4.65% | 17.64× | Reported |
| 2017-12-31 | $181.11M | $1.33B | $56.98M | $150.07M | $9.58M | 13.60% | 4.28% | 15.67× | Reported |
| 2016-12-31 | $141.53M | $1.02B | $40.55M | $134.18M | $2.20M | 13.94% | 3.99% | 61.02× | Reported |
| 2015-12-31 | $128.49M | $926.87M | $28.45M | $166.11M | $66.00K | 13.86% | 3.07% | 2516.76× | Reported |
| 2014-12-31 | $148.56M | $1.01B | $29.81M | $111.83M | $73.00K | 14.69% | 2.95% | 1531.85× | Reported |
| 2013-12-31 | $136.56M | $949.28M | $26.31M | $79.75M | $182.00K | 14.39% | 2.77% | 438.20× | Reported |
| 2012-12-31 | $121.39M | $879.01M | $23.61M | $45.63M | $103.00K | 13.81% | 2.69% | 443.03× | Reported |
| 2011-12-31 | $109.13M | $793.83M | $21.16M | $59.03M | $930.00K | 13.75% | 2.67% | 63.47× | Reported |
| 2010-12-31 | $97.08M | $689.45M | $21.05M | $49.05M | (m) | 14.08% | 3.05% | (m) | (m) |
| 2009-12-31 | $77.38M | $583.12M | $18.24M | $38.20M | (m) | 13.27% | 3.13% | (m) | (m) |
| 2008-12-31 | $78.44M | $624.16M | $25.32M | $37.35M | (m) | 12.57% | 4.06% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.